James Miller - Second Sight Director - Manufacturing
| EYESDelisted Stock | USD 4.14 0.20 4.61% |
Director
Mr. James Miller is Director Manufacturing of the Company. Prior to joining Second Sight Jim Miller worked at Boston Scientific as the Value Stream Production Manager. Among other responsibilities he oversaw the startup of Neuromodulator manufacturing providing direction for manufacturingrelated decisions including staffing layouts equipment capacity and product structures for Spinal Cord Stimulators and Bions. At Pantera Software he served as Senior Manufacturing Consultant specializing in Enterprise Resource Planning and Quality Systems. Prior to that he worked at Sunrise Medical holding several positions of increasing responsibility in manufacturing and quality assurance and at Everest Jennings where he began his career as an Industrial Engineer. He received a BS Degree in Production Operations from California State University Northridge and is Certified in Production and Inventory Management. since 2015.
| Tenure | 9 years |
| Phone | 818 833-5000 |
| Web | www.secondsight.com |
Second Sight Management Efficiency
The company has return on total asset (ROA) of (10.74) % which means that it has lost $10.74 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (19.02) %, meaning that it created substantial loss on money invested by shareholders. Second Sight's management efficiency ratios could be used to measure how well Second Sight manages its routine affairs as well as how well it operates its assets and liabilities.The company currently holds 199 K in liabilities with Debt to Equity (D/E) ratio of 0.0, which may suggest the company is not taking enough advantage from borrowing. Second Sight Medical has a current ratio of 24.75, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Second Sight until it has trouble settling it off, either with new capital or with free cash flow. So, Second Sight's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Second Sight Medical sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Second to invest in growth at high rates of return. When we think about Second Sight's use of debt, we should always consider it together with cash and equity.
Similar Executives
| Showing other executives | DIRECTOR Age | ||
| James Brien | Eastman Chemical | 62 | |
| Mary Schumacher | Hawkins | 60 | |
| Dirk Debbink | Cincinnati Financial | 62 | |
| Gary Anderson | Eastman Chemical | 70 | |
| Humberto Alfonso | Eastman Chemical | 63 | |
| Mary Tidlund | Valhi Inc | 63 | |
| James Kroner | Employers Holdings | 58 | |
| JeanPaul Montupet | Assurant | 73 | |
| Donald Landry | Sensient Technologies | 66 | |
| Paul Reilly | Assurant | 64 | |
| Elaine Wedral | Sensient Technologies | 77 | |
| Charles Koch | Assurant | 72 | |
| Daniel Stauber | Hawkins | 62 | |
| Kenneth Lichtendahl | Cincinnati Financial | 69 | |
| William Bahl | Cincinnati Financial | 66 | |
| Gregory Bier | Cincinnati Financial | 71 | |
| Thomas Barry | Valhi Inc | 76 | |
| James OBrien | Eastman Chemical | 66 | |
| Ben Seaman | Flexible Solutions Internationa | 38 | |
| Harriet Edelman | Assurant | 65 | |
| Lewis Kling | Eastman Chemical | 73 | |
Management Performance
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 |
Second Sight Medical Leadership Team
Elected by the shareholders, the Second Sight's board of directors comprises two types of representatives: Second Sight inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Second. The board's role is to monitor Second Sight's management team and ensure that shareholders' interests are well served. Second Sight's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Second Sight's outside directors are responsible for providing unbiased perspectives on the board's policies.
| John Blake, CFO | ||
| Patrick Ryan, COO | ||
| Frank Vandeputte, Vice President General Manager | ||
| Anthony Moses, Commercial Vice President - Americas | ||
| Edward Randolph, VP of Manufacturing | ||
| Gregg Williams, Independent Director | ||
| Alfred Mann, Co-Founder, Chairman Emeritus, Member of Audit Committee, Member of Nominating and Governance Committee and Member of Compensation Committee | ||
| Jonathan McGuire, President CEO, Director | ||
| Stephen Okland, Commercial Vice President U.S. and Canada | ||
| Gregoire Cosendai, VP of European Operations | ||
| Steven Okland, Commercial Vice President U.S. and Canada | ||
| William Link, Independent Director | ||
| Thomas Miller, CFO | ||
| James Miller, Director - Manufacturing | ||
| Will McGuire, President CEO, Director | ||
| David Jacques, Vice President - Research & Development | ||
| Aaron Mendelsohn, Director | ||
| Robert Greenberg, President CEO, Director | ||
| Matthew Pfeffer, Independent Director |
Second Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Second Sight a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | -19.02 | |||
| Return On Asset | -10.74 | |||
| Current Valuation | 11.54 M | |||
| Shares Outstanding | 39.41 M | |||
| Shares Owned By Insiders | 28.61 % | |||
| Shares Owned By Institutions | 7.01 % | |||
| Number Of Shares Shorted | 1.19 M | |||
| Price To Earning | (1.61) X | |||
| Price To Book | 0.93 X | |||
| Price To Sales | 616.54 X |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Second Sight in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Second Sight's short interest history, or implied volatility extrapolated from Second Sight options trading.
Pair Trading with Second Sight
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Second Sight position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Second Sight will appreciate offsetting losses from the drop in the long position's value.Moving against Second Stock
| 0.66 | BSX | Boston Scientific Corp Financial Report 24th of April 2024 | PairCorr |
| 0.64 | ALGN | Align Technology Financial Report 24th of April 2024 | PairCorr |
| 0.63 | EW | Edwards Lifesciences Corp Financial Report 24th of April 2024 | PairCorr |
| 0.58 | DXCM | DexCom Inc Financial Report 25th of April 2024 | PairCorr |
| 0.51 | ZBH | Zimmer Biomet Holdings Financial Report 7th of May 2024 | PairCorr |
The ability to find closely correlated positions to Second Sight could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Second Sight when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Second Sight - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Second Sight Medical to buy it.
The correlation of Second Sight is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Second Sight moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Second Sight Medical moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Second Sight can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in income. Note that the Second Sight Medical information on this page should be used as a complementary analysis to other Second Sight's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Other Consideration for investing in Second Stock
If you are still planning to invest in Second Sight Medical check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Second Sight's history and understand the potential risks before investing.
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Analyst Advice Analyst recommendations and target price estimates broken down by several categories | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets |